Pub. Date : 2021
PMID : 34457036
7 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517). | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 2 | This meta-analysis was conducted to analyze the effect of NQO1 polymorphism on the warfarin maintenance dosage. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 3 | Review Manager Version 5.4 software was used to analyze the relationship between NQO1 polymorphisms and the warfarin maintenance dosage. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 4 | Patients who were NQO1 rs10517 G carriers (AG carriers or GG carriers) required a 48% higher warfarin maintenance dose than those who were AA carriers. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 5 | Patients with NQO1 rs1800566 CT carriers required a 13% higher warfarin dose than those who were CC carriers, with no associations observed with the other comparisons of the NQO1 rs1800566 genotypes. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 6 | Our meta-analysis suggests that the NQO1 rs10517and NQO1 rs1800566 variant statuses affect the required warfarin maintenance dose. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |
| 7 | Our meta-analysis suggests that the NQO1 rs10517and NQO1 rs1800566 variant statuses affect the required warfarin maintenance dose. | Warfarin | NAD(P)H quinone dehydrogenase 1 | Homo sapiens |